Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aqu Alu

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Clinical and Translational Medicine|September 30, 2020
Hyperprogression: A novel response pattern under immunotherapyXue-Jiao Han, Aqu Alu, Yi-Nan Xiao, et al.
Frontiers in Oncology|August 9, 2021
Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning MethodsXuejiao Han, Jing Yang, Jingwen Luo, et al.
Signal Transduction and Targeted Therapy|August 6, 2025
Immunosenescence: signaling pathways, diseases and therapeutic targetsYichu Fu, Binhan Wang, Aqu Alu, et al.
Cancer Letters|December 5, 2022
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinomaYanlin Song, Yuan Cheng, Tianxia Lan, et al.
Chinese Medical Journal|August 26, 2024
Ginkgo biloba derivative ginkgetin inhibits breast cancer growth by regulating the miRNA-122-5p/GALNT10 axisAqu Alu, Zedong Jiang, Xuejiao Han, et al.
Signal Transduction and Targeted Therapy|November 30, 2025
Integrative analysis of non-small cell lung cancer identifies Jumonji domain-containing 6/ETS homologous factor axis as a target to overcome radioresistanceManni Wang, Li Xu, Aqu Alu, et al.
Signal Transduction and Targeted Therapy|December 14, 2020
Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2Hong Lei, Aqu Alu, Jingyun Yang, et al.
Medcomm|May 1, 2023
A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2Cai He, Aqu Alu, Hong Lei, et al.
Cancer Communications (London, England)|April 10, 2025
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL-1β and the inflammasome pathwayXuejiao Han, Yuan Cheng, Dandan Wan, et al.
Signal Transduction and Targeted Therapy|May 17, 2022
Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variantsHong Lei, Aqu Alu, Jingyun Yang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Clinical and Translational Medicine|September 30, 2020
Hyperprogression: A novel response pattern under immunotherapyXue-Jiao Han, Aqu Alu, Yi-Nan Xiao, et al.
Frontiers in Oncology|August 9, 2021
Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning MethodsXuejiao Han, Jing Yang, Jingwen Luo, et al.
Signal Transduction and Targeted Therapy|August 6, 2025
Immunosenescence: signaling pathways, diseases and therapeutic targetsYichu Fu, Binhan Wang, Aqu Alu, et al.
Cancer Letters|December 5, 2022
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinomaYanlin Song, Yuan Cheng, Tianxia Lan, et al.
Chinese Medical Journal|August 26, 2024
Ginkgo biloba derivative ginkgetin inhibits breast cancer growth by regulating the miRNA-122-5p/GALNT10 axisAqu Alu, Zedong Jiang, Xuejiao Han, et al.
Signal Transduction and Targeted Therapy|November 30, 2025
Integrative analysis of non-small cell lung cancer identifies Jumonji domain-containing 6/ETS homologous factor axis as a target to overcome radioresistanceManni Wang, Li Xu, Aqu Alu, et al.
Signal Transduction and Targeted Therapy|December 14, 2020
Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2Hong Lei, Aqu Alu, Jingyun Yang, et al.
Medcomm|May 1, 2023
A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2Cai He, Aqu Alu, Hong Lei, et al.
Cancer Communications (London, England)|April 10, 2025
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL-1β and the inflammasome pathwayXuejiao Han, Yuan Cheng, Dandan Wan, et al.
Signal Transduction and Targeted Therapy|May 17, 2022
Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variantsHong Lei, Aqu Alu, Jingyun Yang, et al.
Pageof 4